SPP1 and metabolic dysfunction-associated steatohepatitis: On the contrary of OPN neutralizing studies by means of anti‐OPN antibodies,15, 19, 52 completely depleting OPN action disrupts the paradigm that a more severe NASH phenotype will increase the risk of severe fibrosis development and in turn also liver‐related mortality.53, 54, 55, 56